CMS Backs Down On Hospice Drug Restrictions

CMS issued a new memorandum moderating their regulation on “Part D Payment for Drugs for Beneficiaries Enrolled in Hospice.” The new directive limits prior authorization by hospices to four classes of drugs: analgesics, anti-nauseants, laxatives and anti-anxiety drugs. In March, CMS announced that it would require prior approval for all hospice drugs under Medicare Part D prescription drug benefit. The recent change was made after a June meeting between officials and stakeholders including hospice providers, insurers and pharmacies and patient advocates “who described the operational challenges of requiring all hospice drugs to be approved before they could be dispensed.”

Click here to read more.

Advertisements

One thought on “CMS Backs Down On Hospice Drug Restrictions

  1. Pingback: Monday Morning Recap | hmsabc

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s